Development and Validation of Stability indicating RP- HPLC method for Simultaneous Estimation of Sofosbuvir and Ledipasvir in Bulk Tablet Dosage Form
Abstract
The present research work describes a simple, accurate, precise, effective, Stability indicating RP-HPLC method for simultaneous estimation of Sofosbuvir and Ledipasvir in their tablet dosage form. A reverse phase high performance chromatographic method was developed for simultaneous estimation of Sofosbuvir and Ledipasvir their combined dosage. The separation was achieved by Inertsil ODS C18 column (150X4.6mm, 5µm) column, and ACN: 0.1% TFA in the proportion of 30:70 %v/v as mobile phase, at a flow rate of 1 ml/min. Detection was carried out at 245 nm. For RP-HPLC method results of the validation indicate that the method was linear in the range of 100-600μg/ml for Sofosbuvir and 22.5-135μg/ml for Ledipasvir. The % recoveries for Sofosbuvir and Ledipasvir obtained in the accuracy study were 99.92-100.31% and 99.84-100.55% respectively. The LOD for Sofosbuvir and Ledipasvir were found to be 0.395μg/ml and 0.132μg/ml respectively. LOQ for Sofosbuvir and Ledipasvir were found to be 1.197μg/ml and 0.401μg/ml respectively. Force degradation study also done and method is stability indicating. Developed methods were found to be accurate, precise, rapid and stability indicating for simultaneous estimation of Sofosbuvir and Ledipasvir.
Keywords: RP-HPLC, Sofosbuvir, Ledipasvir, ACN, TFA.
DOI
https://doi.org/10.22270/jddt.v9i3-s.2893Published
Abstract Display: 490
PDF Downloads: 605 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.